CISSVSGTBP• 12 Months (Normalized)
CISS vs GTBP (C3is Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CISS Performance $1.1
-99.99%
C3is Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-99.99 pts
GTBP outperforming by 99.99 percentage points
CISSGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CISS GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CISS Price | CISS Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $1.10 | -99.99% | $- | - | |
| Sep 24, 2026 | $1.12 | -99.99% | $- | - | |
| Sep 23, 2026 | $1.10 | -99.99% | $7.10 | +832.98% | -932.97% |
| Sep 22, 2026 | $1.14 | -99.99% | $- | - | |
| Sep 21, 2026 | $1.23 | -99.99% | $7.18 | +843.50% | -943.49% |
| Sep 18, 2026 | $1.29 | -99.99% | $7.16 | +840.87% | -940.86% |
| Sep 17, 2026 | $1.33 | -99.99% | $7.49 | +884.23% | -984.22% |
| Sep 16, 2026 | $1.24 | -99.99% | $7.81 | +926.28% | -1026.27% |
| Sep 15, 2026 | $1.25 | -99.99% | $9.00 | +1082.65% | -1182.64% |
| Sep 14, 2026 | $1.37 | -99.99% | $11.63 | +1428.25% | -1528.24% |
| Sep 11, 2026 | $1.37 | -99.99% | $8.61 | +1031.41% | -1131.40% |
| Sep 10, 2026 | $1.45 | -99.99% | $6.18 | +712.09% | -812.08% |
| Sep 09, 2026 | $1.42 | -99.99% | $5.98 | +685.81% | -785.80% |
| Sep 08, 2026 | $1.46 | -99.99% | $- | - | |
| Sep 04, 2026 | $1.49 | -99.99% | $0.24 | -68.33% | -31.66% |
Page 1 of 17